1. Protein kinase D at the Golgi controls NLRP3 inflammasome activation
- Author
-
Zhang, Zhirong, Meszaros, Gergö, He, Wan-ting, Xu, Yanfang, Fatima Magliarelli, Helena de, Mailly, Laurent, Mihlan, Michael, Liu, Yansheng, Puig Gámez, Marta, Goginashvili, Alexander, Pasquier, Adrien, Bielska, Olga, Neven, Bénédicte, Quartier, Pierre, Aebersold, Rudolf, Baumert, Thomas F., Georgel, Philippe, Han, Jiahuai, Ricci, Romeo, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Centre for Integrative Biology - CBI (Inserm U964 - CNRS UMR7104 - IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Université de Strasbourg (UNISTRA), inserm U1110, Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Immuno-Rhumatologie Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Strasbourg (UNISTRA), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institute of genetics and molecular and cellular biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire (INSERM/CNRS), INSERM/CNRS, Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunorhumathologie moléculaire, and Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Mice, Knockout ,Leukocytes, Mononuclear/metabolism ,NLR Family, Pyrin Domain-Containing 3 Protein/*physiology ,integumentary system ,Innate immunity and inflammation ,Protein Kinase C/*physiology ,Sciences du Vivant [q-bio]/Médecine humaine et pathologie ,Mice, Inbred C57BL ,Mice ,Endoplasmic Reticulum/physiology ,Humans ,Golgi Apparatus/*physiology ,Phosphorylation ,Diglycerides/metabolism ,Inflammasomes/*physiology ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Human disease genetics - Abstract
The inflammasomes are multiprotein complexes sensing tissue damage and infectious agents to initiate innate immune responses. Different inflammasomes containing distinct sensor molecules exist. The NLRP3 inflammasome is unique as it detects a variety of danger signals. It has been reported that NLRP3 is recruited to mitochondria-associated endoplasmic reticulum membranes (MAMs) and is activated by MAM-derived effectors. Here, we show that in response to inflammasome activators, MAMs localize adjacent to Golgi membranes. Diacylglycerol (DAG) at the Golgi rapidly increases, recruiting protein kinase D (PKD), a key effector of DAG. Upon PKD inactivation, self-oligomerized NLRP3 is retained at MAMs adjacent to Golgi, blocking assembly of the active inflammasome. Importantly, phosphorylation of NLRP3 by PKD at the Golgi is sufficient to release NLRP3 from MAMs, resulting in assembly of the active inflammasome. Moreover, PKD inhibition prevents inflammasome autoactivation in peripheral blood mononuclear cells from patients carrying NLRP3 mutations. Hence, Golgi-mediated PKD signaling is required and sufficient for NLRP3 inflammasome activation. ISSN:0022-1007 ISSN:1540-0069 ISSN:1540-9538
- Published
- 2017